Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/KNE stock hub

TSXV/KNE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/KNEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.4M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/KNE

In the news

Latest news · TSXV/KNE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-155.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/KNE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

CAD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 7.8M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA4838092084
Last refreshed	2026-05-10
Market cap	CAD 6.4M
Price	CAD 0.04
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsxv/KNE
Website	https://kanebiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-42.75%
EV Earnings	-2.85x
EV/FCF	-2.38x
EV/Sales	18.15x
FCF yield	-51.22%
P/B ratio	-8.53x
P/S ratio	14.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-0.15%
Gross Profit	CAD -640
Net Income	CAD -2.7M
Net Income Growth Years	2%
Pretax Margin	-661.24%
ROA	-62.39
Roa5y	-49.39
ROCE	-1,123.9
ROIC	-155.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-14.87%
Cagr15y	-18.48%
Cagr1y	-56.27%
Cagr20y	-19.45%
Cagr3y	-29.52%
Cagr5y	-29.08%
EPS Growth Years	2
Revenue Growth	-79.44x
Revenue Growth Years	0x
Revenue Growth3 Y	39.76x
Revenue Growth5 Y	-20.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.16
Assets	CAD 2.7M
Cash	CAD 901,698
Current Assets	CAD 1.7M
Current Liabilities	CAD 2.5M
Debt	CAD 2.3M
Debt FCF	CAD -0.71
Equity	CAD -746,545
Interest Coverage	-10.75
Liabilities	CAD 3.5M
Long Term Assets	CAD 1M
Long Term Liabilities	CAD 978,714
Net Cash	CAD -1.4M
Net Cash By Market Cap	CAD -22.04
Tangible Book Value	CAD -1.3M
Tangible Book Value Per Share	CAD -0.01
WACC	6.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.68
Inventory Turnover	0.97
Net Working Capital	CAD -388,723
Quick ratio	0.38
Working Capital	CAD -812,619
Working Capital Turnover	CAD -0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-80%
1Y total return	-56.25%
200-day SMA	0.04
3Y total return	-65%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-82.05%
All Time High	4.5
All Time High Change	-99.22%
All Time High Date	2005-01-13
All Time Low	0.03
All Time Low Change	40%
All Time Low Date	2025-10-28
ATR	0
Beta	0.25
Beta1y	1.2
Beta2y	0.63
Ch YTD	-12.5
High	0.04
High52	0.09
High52 Date	2025-05-08
High52ch	-58.82%
Low	0.04
Low52	0.03
Low52 Date	2025-11-04
Low52ch	40%
Ma50ch	0%
Price vs 200-day SMA	-11.39%
RSI	52.09
RSI Monthly	33.39
RSI Weekly	43.76
Sharpe ratio	-0.23x
Sortino ratio	-0.3
Total Return	-4.4%
Tr YTD	-12.5
Tr15y	-95.33%
Tr1m	16.67%
Tr3m	-12.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.6M
Operating margin	-609.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	101,935,975%
Net Borrowing	665,738
Shares Insiders	43.95%
Shares Out	181,856,565
Shares Qo Q	-46.46%
Shares Yo Y	4.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -3.2M
Average Volume	227,577.9x
Bv Per Share	-0
CAPEX	CAD -4,895
Ch10y	-80
Ch15y	-95.33
Ch1m	16.67
Ch1y	-56.25
Ch20y	-98.68
Ch3m	-12.5
Ch3y	-65
Ch5y	-82.05
Ch6m	16.67
Change	0%
Change From Open	-12.5
Close	0.04
Days Gap	14.29
Depreciation Amortization	61,466
Dollar Volume	30,415
Earnings Date	2026-05-12
EBIT	CAD -2.6M
EBITDA	CAD -2.5M
EPS	CAD -0.02
F Score	2
FCF	CAD -3.3M
FCF EV Yield	-41.97x
FCF Per Share	CAD -0.02
Financing CF	3,851,436
Fiscal Year End	December
Founded	2,001
Income Tax	CAD -108,005
Investing CF	-53,133
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-12-31
Last Split Date	2017-03-13
Last Split Type	Reverse
Ma150	0.04
Ma150ch	-5.66%
Ma20	0.03
Ma20ch	4.48%
Net CF	542,885
Next Earnings Date	2026-05-12
Open	0.04
Position In Range	0
Ppne	476,488
Price Date	2026-05-08
Relative Volume	4.36x
Revenue	427,869x
SBC By Revenue	-19.39x
Share Based Comp	-82,966
Tax By Revenue	-25.24x
Tr20y	-98.68%
Tr6m	16.67%
Volume	869,000
Z Score	-20.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/KNE pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/KNE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/KNE?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+43.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.4%

Negative means the company is buying back shares.

Technical

TSXV/KNE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.1

Neutral momentum band

Price vs 200-day MA

-11.4%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/KNE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/KNE stock rating?

tsxv/KNE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/KNE analysis?

The full report lives at /stocks/tsxv/KNE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/KNE?

The latest report frames tsxv/KNE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/KNE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.